Non-Injectable Insulin Market Size, Share, Revenue, Trends And Drivers For 2024-2033

The Business Research Company’s Non-Injectable Insulin Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033

LONDON, GREATER LONDON, UK, June 21, 2024 /EINPresswire.com/ -- Non-injectable insulin, a type of insulin that can be administered without injections, is revolutionizing diabetes management by offering alternatives to traditional insulin delivery methods. These innovations aim to improve patient compliance, address needle phobia, and enhance overall quality of life for individuals with diabetes.

Market Size and Growth
The non-injectable insulin market is projected to grow from $1.71 billion in 2023 to $1.92 billion in 2024, representing a compound annual growth rate (CAGR) of 12.2%. This growth is attributed to factors such as improving patient compliance, addressing needle phobia, enhancing quality of life, ease of administration, and stable blood glucose control.
Looking ahead, the market is expected to experience rapid growth, reaching $2.89 billion by 2028, with a CAGR of 10.7%. This growth will be driven by continued emphasis on patient compliance, solutions for needle phobia, quality of life improvements, safety enhancements, and reduced infection and injury risks.

Explore comprehensive insights into the global Non-Injectable Insulin market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=13888&type=smp

Driver: Rising Obesity and Diabetes Issues
The rising prevalence of obesity and diabetes is expected to drive the growth of the non-injectable insulin market. With global obesity rates expected to surge and an increasing number of people at risk of acquiring type 2 diabetes, non-injectable insulin offers a potential solution by improving management, addressing barriers to insulin therapy, and providing more convenient treatment options.

Major Players and Market Trends
Major companies such as Pfizer Inc., Johnson & Johnson, and F. Hoffmann-La Roche Ltd. are focusing on innovative advancements in drug delivery technologies, such as needle-free oral insulin spray. This technology offers a painless and convenient alternative for regulating blood glucose levels, potentially improving the lives of individuals managing diabetes with multiple insulin injections.

Segments
The non-injectable insulin market is segmented based on type, product, and distribution channel:
1. Type: Synthetic Insulin, Semi Synthetic Insulin
2. Product: Pills, Sprays, Other Products
3. Distribution Channel: Hospital Pharmacies, Online Pharmacies, Drug Stores

Geographical Insights
North America was the largest region in the non-injectable insulin market in 2023, with Asia-Pacific expected to be the fastest-growing region in the forecast period.

Access the complete report for an in-depth analysis of the global Non-Injectable Insulin market: https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

Non-Injectable Insulin Global Market Report 2024 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Non-Injectable Insulin Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on non-injectable insulin market size, non-injectable insulin market drivers and trends, non-injectable insulin market major players, competitors' revenues, market positioning, and market growth across geographies. The non-injectable insulin market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Insulin Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Insulin Patch Pumps Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn